Home

Mark Lappe, CEO: Inhibrx Biosciences INBX Buy · Filed 24/08/22

Trade details

Type
Insider buy
Amount
$167,378.85
Shares · price
12,945 sh · $12.93 a share
Held after
54,865 sh
Trade date
24/08/21
Filed
24/08/22
Days to filing
1 days

First buy since 2023

Insiders buying this week
3 insiders
Holding change
+30.9%

Inhibrx Biosciences trades, last 26 weeks

What else happened in Inhibrx Biosciences around then

Filed or reported within 30 days of the trade day · 24/07/22~24/09/20

Mark Lappe's recent trades

  • Mark Lappe

    BuyInhibrx Biosciences

    $328.6K

    Filed 09/28

  • Mark Lappe

    BuyInhibrx Biosciences

    $305.1K

    Filed 09/28

  • Mark Lappe

    BuyInhibrx Biosciences

    $216.7K

    Filed 09/28

  • Mark Lappe

    BuyInhibrx Biosciences

    $148.3K

    Filed 09/28

  • Mark Lappe

    BuyInhibrx Biosciences

    $405.8K

    Filed 24/09/16